LaBrecque DR,Abbas Z,Anania F,Ferenci P,Khan AG,Goh KL .2014 .World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J Clin Gastroenterol, 48(6) : 467-73.
Hashimoto E,Taniai M .2013 .Tokushige K. Characteristics and diagnosis of NAFLD/NASH. , 28(Suppl 4) : 64-70.
Lee YH,Cho Y,Lee BW,Park CY,Lee DH,Cha BS .2019 .Nonalcoholic fatty liver disease in diabetes. Part I: Epidemiology and diagnosis. Diabetes Metab J, 43(1) : 2Fdmj-45.
El Azeem HA,Khalek el-SA,El-Akabawy H,Naeim H,Khalik HA,Alfi AA .2013 .Association between nonalcoholic fatty liver disease and the incidence of cardiovascular and renal events. J Saudi Heart Assoc, 07(4) : 239-46.
Wong VW,Wong GL,Tsang SW,Fan T,Chu WC,Woo J .2011 .High prevalence of colorectal neoplasm in patients with nonalcoholic steatohepatitis. Gut, 60(6) : 829-36.
Machado MV,Cortez-Pinto H MV .2012 .Fatty liver in lean patients: is it a diferent disease?. Ann Gastroenterol, 25(1) : 1-2.
Sahakyan KR,Somers VK,Rodriguez-Escudero JP,Hodge DO,Carter RE,Sochor O .2015 .Normal-weight central obesity: implications for total and cardiovascular mortality. Ann Intern Med, 163(11) : 2525-35.
Ha Y,Seo N,Shim JH,Kim SY,Park JA,Han S .2015 .Intimate association of visceral obesity with non-alcoholic fatty liver disease in healthy Asians: A case-control study. J Gastroenterol Hepatol, 30(11) : 1666-72.
Feldman A,Eder SK,Felder TK,Kedenko L,Paulweber B,Stadlmayr A .2016 .Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver. Am J Gastroenterol, 112(1) : 102-10.
Szczepaniak LS,Nurenberg P,Leonard D,Browning JD,Reingold JS,Grundy S .2005 .Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab, 288(2) : E462-8.
Deedwania PC,Hunninghake DB,Bays HE,Jones PH,Cain VA,Blasetto JW .2004 .Efects of rosuvastatin, atorvastatin, simvastatin, and pravastatin on atherogenic dyslipidemia in patients with characteristics of the metabolic syndrome. Am J Cardiol, 09(3) : 360-6.
Lim JU,Lee JH,Kim JS,Hwang YI,Kim TH,Lim SY .2017 .Asia-Pacific body mass index classifications in COPD patients. Int J Chron Obstruct Pulmon Dis, 12 : 2465-75.
Huang PL .2009 .A comprehensive definition for metabolic syndrome. Dis Model Mech, 2(5) : 231-7.
Kim HJ,Kim HJ,Lee KE,Kim DJ,Kim SK,Ahn CW .2004 .Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med, 164(19) : 2169-75.
Bellentani S,Saccoccio G,Masutti F,Crocè LS,Brandi G,Sasso F .2000 .Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med, 132(2) : 200001180-7.
Akbar DH,Kawther AH .2003 .Nonalcoholic fatty liver disease in Saudi type 2 diabetic subjects attending a medical outpatient clinic: prevalence and general characteristics. Diabetes Care, 26(12) : 3351-2.
Niaz A,Ali Z,Nayyar S,Fatima N. .2011 .Prevalence of NAFLD in healthy and young male individuals. ISRN Gastroenterol, : 2F363546.
Zheng W,McLerran DF,Rolland B,Zhang X,Inoue M,Matsuo K .2011 .Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med, 364(8) : 719-29.
Dela Cruz AC,Bugianesi E,George J,Day CP,Liaquat H,Charatcharoenwitthaya P .2014 .5): S-909. Gastroenterology, 5085(14) : 63307-2.
Zein CO,Unalp A,Colvin R,Liu YC,McCullough AJ .2010 .Nonalcoholic Steatohepatitis Clinical Research Network. Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease. J Hepatol, 07(4) : 753-9.
Lo L,McLennan SV,Williams PF,Bonner J,Chowdhury S,McCaughan GW .2010 .Diabetes is a progression factor for hepatic ifbrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis. J Hepatol, 10(2) : 435-44.
Starley BQ,Calcagno CJ,Harrison SA .2010 .Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology, 51(5) : 1820-32.
Hebbard L,George J .2010 .Animal models of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol, 8(1) : 35-44.
Chowdhry MAT,Butt NI,Shakeel H,Gondal MNF,Saeed H. Tahir H MNF .2021 .Is lack of patient knowledge a cause of poorly controlled diabetes mellitus. PJMHS, 15(9) : 2302-4.
Zia N,Aftab S,Butt NI,Ashfaq F,Anser A,Saeed S. .2093 .Prevalence of silent cardiac ischemia in type II diabetes mellitus. Pak Heart J, 54(2) : 162-6.
Afzal H,Butt NI,Ashfaq F,Habib O,Anser A,Aftab S. .2023 .Obstructive sleep apnea in type 2 diabetes mellitus. RMJ, 48(1) : 20-2.
Meo SA,Zia I,Bukhari IA,Arain SA .2016 .Type 2 diabetes mellitus in Pakistan: Current prevalence and future forecast. J Pak Med Assoc, 66(12) : 1637-42.
Radu F,Potcovaru CG,Salmen T,Filip PV,Pop C,FierbințeanuBraticievici C. C .2023 .The link between NAFLD and metabolic syndrome. Diagnostics, 13(4) : 614.
Barale C,Russo I. .2020 .Influence of cardiometabolic risk factors on platelet function. Int J Mol Sci, 21(2) : 623.
Lemieux I,Després JP .2020 .Metabolic syndrome: past, present and future. Nutrients, 12(11) : 3501.
Riazi K,Azhari H,Charette JH,Underwood FE,King JA,Afshar EE .2022 .The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol, 1253(22) : 00165-0.
Anwar A,Butt NI,Ashfaq F,Aftab S,Nasim H,Khan FA .2022 .Elevated CRP level in metabolic syndrome. RMJ, 47(4) : 837-40.
Jin YJ,Kim KM,Hwang S,Lee SG,Ha TY,Song GW .2012 .Exercise and diet modification in non-obese non-alcoholic fatty liver disease: analysis of biopsies of living liver donors. J Gastroenterol Hepatol, 07165(8) : 1746-7.
Xu R,Pan J,Zhou W,Ji G,Dang Y. .2022 .Recent advances in lean NAFLD. Biomed Pharmacother, 153 : 113331.